CGS-CIMB Research analyst Tay Wee Kuang is keeping his “add” call on Hyphens Pharma International (SGX:1J5) but at a lowered target price of 32 cents from 34 cents previously, following the company’s 3QFY2023 ended Sept 30 results.
Hyphens Pharma International
Price target:
CGS-CIMB Research ‘add’ 32 cents
Supply constraints

